IBDEI0L4 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10352,1,4,0)
 ;;=4^695.12
 ;;^UTILITY(U,$J,358.3,10352,1,5,0)
 ;;=5^Erythema Multiforme,Major
 ;;^UTILITY(U,$J,358.3,10352,2)
 ;;=^336635
 ;;^UTILITY(U,$J,358.3,10353,0)
 ;;=695.13^^67^674^67
 ;;^UTILITY(U,$J,358.3,10353,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10353,1,4,0)
 ;;=4^695.13
 ;;^UTILITY(U,$J,358.3,10353,1,5,0)
 ;;=5^Stevens-Johnson Syndrome
 ;;^UTILITY(U,$J,358.3,10353,2)
 ;;=^336636
 ;;^UTILITY(U,$J,358.3,10354,0)
 ;;=695.14^^67^674^59
 ;;^UTILITY(U,$J,358.3,10354,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10354,1,4,0)
 ;;=4^695.14
 ;;^UTILITY(U,$J,358.3,10354,1,5,0)
 ;;=5^SJS-TEN Syndrome
 ;;^UTILITY(U,$J,358.3,10354,2)
 ;;=^336637
 ;;^UTILITY(U,$J,358.3,10355,0)
 ;;=695.15^^67^674^71
 ;;^UTILITY(U,$J,358.3,10355,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10355,1,4,0)
 ;;=4^695.15
 ;;^UTILITY(U,$J,358.3,10355,1,5,0)
 ;;=5^Toxic Epidermal Necrolysis
 ;;^UTILITY(U,$J,358.3,10355,2)
 ;;=^336638
 ;;^UTILITY(U,$J,358.3,10356,0)
 ;;=695.19^^67^674^30
 ;;^UTILITY(U,$J,358.3,10356,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10356,1,4,0)
 ;;=4^695.19
 ;;^UTILITY(U,$J,358.3,10356,1,5,0)
 ;;=5^Erythema Multiforme NEC
 ;;^UTILITY(U,$J,358.3,10356,2)
 ;;=^336639
 ;;^UTILITY(U,$J,358.3,10357,0)
 ;;=V18.0^^67^675^15
 ;;^UTILITY(U,$J,358.3,10357,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10357,1,4,0)
 ;;=4^V18.0
 ;;^UTILITY(U,$J,358.3,10357,1,5,0)
 ;;=5^Family h/o Diabetes Mellitus
 ;;^UTILITY(U,$J,358.3,10357,2)
 ;;=^295311
 ;;^UTILITY(U,$J,358.3,10358,0)
 ;;=V16.0^^67^675^7
 ;;^UTILITY(U,$J,358.3,10358,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10358,1,4,0)
 ;;=4^V16.0
 ;;^UTILITY(U,$J,358.3,10358,1,5,0)
 ;;=5^Family h/o Cancer of GI Tract
 ;;^UTILITY(U,$J,358.3,10358,2)
 ;;=^295292
 ;;^UTILITY(U,$J,358.3,10359,0)
 ;;=V16.1^^67^675^8
 ;;^UTILITY(U,$J,358.3,10359,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10359,1,4,0)
 ;;=4^V16.1
 ;;^UTILITY(U,$J,358.3,10359,1,5,0)
 ;;=5^Family h/o Cancer of Lung
 ;;^UTILITY(U,$J,358.3,10359,2)
 ;;=^295293
 ;;^UTILITY(U,$J,358.3,10360,0)
 ;;=V19.6^^67^675^1
 ;;^UTILITY(U,$J,358.3,10360,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10360,1,4,0)
 ;;=4^V19.6
 ;;^UTILITY(U,$J,358.3,10360,1,5,0)
 ;;=5^Family h/o Allergic Disorder
 ;;^UTILITY(U,$J,358.3,10360,2)
 ;;=^295326
 ;;^UTILITY(U,$J,358.3,10361,0)
 ;;=V18.2^^67^675^2
 ;;^UTILITY(U,$J,358.3,10361,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10361,1,4,0)
 ;;=4^V18.2
 ;;^UTILITY(U,$J,358.3,10361,1,5,0)
 ;;=5^Family h/o Anemia
 ;;^UTILITY(U,$J,358.3,10361,2)
 ;;=^295313
 ;;^UTILITY(U,$J,358.3,10362,0)
 ;;=V17.5^^67^675^4
 ;;^UTILITY(U,$J,358.3,10362,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10362,1,4,0)
 ;;=4^V17.5
 ;;^UTILITY(U,$J,358.3,10362,1,5,0)
 ;;=5^Family h/o Asthma
 ;;^UTILITY(U,$J,358.3,10362,2)
 ;;=^295307
 ;;^UTILITY(U,$J,358.3,10363,0)
 ;;=V17.7^^67^675^3
 ;;^UTILITY(U,$J,358.3,10363,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10363,1,4,0)
 ;;=4^V17.7
 ;;^UTILITY(U,$J,358.3,10363,1,5,0)
 ;;=5^Family h/o Arthritis
 ;;^UTILITY(U,$J,358.3,10363,2)
 ;;=^295309
 ;;^UTILITY(U,$J,358.3,10364,0)
 ;;=V19.0^^67^675^5
 ;;^UTILITY(U,$J,358.3,10364,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10364,1,4,0)
 ;;=4^V19.0
 ;;^UTILITY(U,$J,358.3,10364,1,5,0)
 ;;=5^Family h/o Blindness
 ;;^UTILITY(U,$J,358.3,10364,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,10365,0)
 ;;=V16.3^^67^675^6
 ;;^UTILITY(U,$J,358.3,10365,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10365,1,4,0)
 ;;=4^V16.3
 ;;^UTILITY(U,$J,358.3,10365,1,5,0)
 ;;=5^Family h/o Cancer of Breast
 ;;^UTILITY(U,$J,358.3,10365,2)
 ;;=^295295
